Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omecamix sodium for reversal of rocuronium-induced neuromuscular block
CTR20181917Phase 2Completed
- Sponsor
- Zhejiang Xianju Pharmaceutical Co., Ltd.
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aomexone sodium in neuromuscular block (NMB), sponsored by Zhejiang Xianju Pharmaceutical Co., Ltd.. Started Oct 2018; status: completed.
02
Drugs
aomexone sodium
03
Conditions
neuromuscular block (NMB)
Beyond the preview
Go deeper on CTR20181917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181917.